Next Article in Journal
Natural Antioxidant-Loaded Nanoemulsions for Sun Protection Enhancement
Next Article in Special Issue
Brevundimonas aurantiaca M3d10, Isolated from the Olive Fly, Produces Hydroxylated Astaxanthin
Previous Article in Journal
Structural and Photoprotective Characteristics of Zn-Ti, Zn-Al, and Mg-Al Layered Double Hydroxides—A Comparative Study
Previous Article in Special Issue
Modulation of Cutaneous Carotenoid Content via Ozone Exposure
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Ultraviolet Filters for Cosmetic Applications

by
Georgiana Nitulescu
*,
Dumitru Lupuliasa
,
Ines Adam-Dima
and
George Mihai Nitulescu
Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Cosmetics 2023, 10(4), 101; https://doi.org/10.3390/cosmetics10040101
Submission received: 16 June 2023 / Revised: 7 July 2023 / Accepted: 11 July 2023 / Published: 12 July 2023
(This article belongs to the Special Issue Feature Papers in Cosmetics in 2023)

Abstract

:
Sunscreens reduce the occurrence risk of skin disorders such as sunburn, skin aging, and cancer through their ability to absorb, reflect, and scatter ultraviolet (UV) radiation. This review provides an overview of UV filters as active ingredients of sunscreen products, emphasizing their classification and structural characteristics. Their photostability, mechanism of action of ultraviolet radiation absorption, optical properties, and regulatory status are discussed based on their chemical structure. The main classes of organic UV filters presented include aminobenzoic acid derivatives, salicylic acid derivatives, cinnamic acid derivatives, benzophenones, dibenzoylmethane derivatives, benzylidene camphor derivatives, triazines, benzimidazole derivatives, and benzotriazole derivatives. The pursuit of new UV filters through research is crucial in advancing sunscreen technology and ensuring the availability of effective and safe options for sun protection.

1. Introduction

A high quantity of scientific evidence has established that photoprotectors, particularly sunscreens, play a vital role in reducing the occurrence of skin disorders (caused by UV radiation) [1]. Sunscreens were commercially introduced on the market almost a century ago and have constantly gained global recognition as an essential component of sun protection strategies [2]. Their efficacy in preventing and mitigating the detrimental effects of UV light stems from their capacity to absorb, reflect, and scatter solar rays. Throughout the years, sunscreens have undergone progressive improvements, both in terms of their active ingredients and also in terms of their cosmetic formulation [3,4].
Researchers and manufacturers are actively working on developing new UV filters with improved photostability and reduced environmental impact. Alternative ingredients and formulations are being explored to provide effective sun protection while minimizing potential risks [3]. Regulatory bodies are also implementing stricter regulations and restrictions on the use of UV filters to protect both human health and the environment [5,6].
In this review, we have carried out an extensive literature survey with respect to the emerging concerns over the efficiency and safety of existing chemical UV filters used in current topical sunscreen products. This article comprehensively reviews the properties, safety, health, and environmental concerns of various UV filters in direct relationship with their chemical structures.

2. Physical and Biological Properties of UV Radiation

Solar light represents the electromagnetic radiation emitted by the sun. The portion of the electromagnetic spectrum perceived with the human eye is known as the visible spectrum and consists of wavelengths ranging from approximately 380 nm, which appears as violet, to 700 nm, which appears as red. Ultraviolet (UV) radiation ranges from 100 to 380 nm and, based on its wavelength, can be categorized as UVA (320–380 nm), UVB (280–320 nm), and UVC (100–280 nm) [7]. It should be noted that these values for the delimitation of specific UV bands are mainly used in a biology setting, and differ slightly from the standard ones imposed by the Commission Internationale de l’Eclairage (CIE, International Commission on Illumination, Vienna, Austria) [8].
UVA rays have wavelengths ranging from 320 to 400 nm and lower energy compared with UVB radiation, but higher dermic penetration. Their spectrum is typically divided into short-wave UVA (UVA2, 320–340 nm) and long-wave UVA (UVA1, 340–400 nm) [9].
In radiometry, UV radiation is described by its power, typically expressed in watts per square meter (W/m2), and by transmitted energy received over a given time period. It is usually expressed in joules per square meter (J/m2) [10]. In the context of the biological effects of skin exposure to light, these measurements are rarely used. The preferred measurement is the minimal erythemal dose (MED). It refers to the smallest amount of UV radiation exposure required to produce a sharp-edge erythema after a specific unit of time [11].
UV radiation has predominantly been associated with detrimental impacts on the skin, leading to sunburn, inflammation, skin cancer, and premature aging. Continuous exposure to UVA radiation prompts the thickening of the outermost layer of the skin (epidermal hyperplasia) and modifies the thickness of the protective layer, called the stratum corneum. On the other hand, chronic UVB exposure triggers harmful consequences, such as DNA damage and the generation of reactive oxygen species (ROS) [12,13]. UV radiation also has beneficial effects; it interacts with 7-dehydrocholesterol (provitamin D) and converts it into vitamin D. Vitamin D plays a crucial role in facilitating the absorption of calcium, necessary for the formation and maintenance of healthy bones. Since only approximately half of the required vitamin D amount is obtained through dietary sources, it is essential to have adequate exposure to UVR in order to maintain optimal health [14].

3. Chemical Characteristics of UV Filters

A sunscreen is defined as a commercial topical preparation capable of providing skin protection against the harmful effects of UV radiation through various mechanisms [1]. A UV filter is a compound that impedes the passage of UV radiation by absorbing or blocking it [15]. A sunscreen is a multicomponent product that contains at least one UV filter, but frequently a mixture of them, and additional substances like surfactants, preservatives, and stabilizers [16,17]. The term “sunscreening agent” is an ambiguous term and should not be used.
The most-used classification of UV filters categorizes them as inorganic and organic compounds [1,2]. The organic filters are often called “chemical” filters, in opposition to the inorganic filters that are considered to have a "physical" mechanism. The term is regarded by some authors as misleading because it induces the idea of the existence of “nonchemical” filters [18].
UV filters are characterized primarily by the value of their absorption peak, also known as lambda max (λmax), referring to the wavelength of light at which the substance absorbs the most, and the value of the molar absorptivity coefficient (ε) at the peak’s wavelength [19,20]. These parameters are directly influenced by the chemical structure and determine the range of UV protection. The λmax conditions refer to which portion of the UV spectrum the filter effectively absorbs and is used for. Thus, UV filters can be classified as UVA, UVB, or broad-spectrum UV filters (UVA and UVB) [5].
Even if the whole chemical structure can influence the optical properties of the compound, the most important element is the structure of the chromophore. With a few exceptions, all the approved UV filters contain an aromatic ring and a carbonyl group bound directly to the aromatic core or linked by a carbon-carbon double bond, forming multiple conjugated π-electron systems [15]. The aromatic ring is usually substituted with an electron-donating group in the para or in the ortho positions. The influence of the substitution position can be observed by analyzing the values of the absorption peaks and the molar absorptivity coefficients of the aminobenzoic acid esters. The compounds substituted in para have a lower λmax compared with those substituted in ortho, but a significantly higher absorption capacity. The same bathochromic and hypochromic effect can be observed when comparing the absorption peaks of the salicylic acid esters with their analogs, the parabens [20]. Some compounds were developed based on the combination of chromophores.
The UV filters also contain various structural elements essential for their specific physico-chemical profile. Many compounds contain a branched alkyl or cycloalkyl fragment that renders the molecule highly lipophilic, while other compounds contain ionizable groups as a strategy for salt formation. The sulfonic acid moiety emerges as the most used.
The water solubility is used as a predictor of the aquatic toxicity. Therefore, it is expected that the compounds containing sulphonic acid moieties present higher toxicities. On the other hand, the lipophilic compounds have a high tendency for bioaccumulation and accumulation in sediments or soils [21].
The organic UV filters are classified based on common chemical scaffolds, and the most important classes are: aminobenzoic acid derivatives, salicylic acid derivatives, cinnamic acid derivatives, benzophenones, dibenzoylmethane derivatives, benzylidenecamphor derivatives, triazines, benzimidazole derivatives, and benzotriazole derivatives.

4. para-Aminobenzoic Acid Esters

para-aminobenzoic acid (PABA) was a key ingredient in many sunscreen products used during the mid-20th century due to its ability to absorb UVB rays and provide protection against sunburns. Its use diminished greatly over the years because of its low photostability and the risks of producing skin irritation, allergies, and contact dermatitis in some individuals [22]. Several esters of PABA, like glyceryl PABA (synonym: lisadimate), amyl 4-(dimethylamino)benzoate (synonym: padimate A), and isoamyl 4-(dimethylamino)benzoate (synonym: padimate), were frequently used in the past, but were abandoned because of the associated risk of phototoxic reactions [23,24]. In the case of the glyceryl PABA, the photocontact allergy seems to be produced by chemical impurities, and not by the substance itself [25].
The PABA derivatives absorb wavelengths in the 290–320 nm range, being effective against UVB radiation and with little effect against UVA radiation [26].
The structures of representative PABA esters are presented in Figure 1.

4.1. Ethylhexyl Dimethyl PABA

2-Ethylhexyl 4-(dimethylamino)benzoate (INCI), also identified in the literature as padimate O (USAN) and octyl dimethyl PABA, is a sunscreen agent approved by both the US Food and Drug Administration (FDA) and the European Union (EU) in all types of cosmetic products at concentrations up to 8% [27,28]. It is a yellow oily liquid insoluble in water, but soluble in ethanol, and chemically very similar to amyl 4-(dimethylamino)benzoate [29]. It has a λmax of 311 nm and the value of ε is referenced as 27,300 mol−1 cm−1 [20]. A stability test indicated a rapid decomposition after irradiation with UVA light through a N-dealkylation reaction, and by a N-oxidation reaction, without considerably altering the absorption spectrum [30].
The risk assessment study concluded that ethylhexyl dimethyl PABA produces no significant reproductive and developmental toxicity or genotoxicity, carcinogenicity, skin sensitization or irritation, or phototoxicity [31].

4.2. Ethoxylated Ethyl-4-aminobenzoate

Ethoxylated ethyl-4-aminobenzoate (INCI), also referred to in the literature as polyethylene glycol (25) PABA or PEG-25 PABA, is approved by the EU, but not by the FDA. It can be used in all types of cosmetic products at concentrations up to 10%. Chemically, it is a PABA moiety ethoxylated with an average of 25 oxy-1,2-ethanediyl units [7,28].

5. Salicylic Acid Derivatives

The benzyl salicylate is credited as the first UV filter used in a cosmetic product [32]. Due to its ortho substitution, it is able to form intramolecular hydrogen bonds and exhibit peak absorption at higher values (∼300 nm) compared with its non-ortho substituted analogs [33]. Salicylates are weak UVB absorbers and are generally used in combination with other UV sunscreens [34,35]. Due to their photostability, they are frequently combined with photolabile UVA filters, such as avobenzone [2]. Regardless of their low extinction coefficients, salicylates have the advantage of a minimal solvatochromic shift and, therefore, a wider range of possible formulations with little effect on the wavelengths’ protection range [36].
The structures of representative salicylic acid derivatives used as UV filters are presented in Figure 2.

5.1. 2-Ethylhexyl Salicylate

This is also referred to as octisalate (INN) [37] and is structurally similar to padimate O, differing only in the substitution of the para-dimethylamino moiety with the ortho-hydroxyl group. It is approved by the FDA and the EU in all types of cosmetic products at concentrations up to 5% [38].
A randomized clinical trial (NCT03582215) concluded that the maximum plasma concentration of octisalate was greater than the FDA’s systemic exposure threshold (0.5 ng/mL) for waiving additional safety studies [39]. Nevertheless, these findings offer no evidence of systemic toxicity, only highlighting that there are insufficient data to determine whether octisalate can be classified as safe [40].

5.2. Homosalate

Homosalate (INN), also known as homomenthyl salicylate, is chemically referred to as 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate. Its maximum absorption wavelength is 306 nm, almost equal to that (307 nm) of its structural analog, octisalate. The value of ε is 4300 mol−1 cm−1 [35]. It is approved by the FDA for a maximum concentration of 15% and is one of the most frequently used UVB filters in sunscreen products in the US [35,41]. In the EU, it is approved at a concentration up to 7.34% for face products, with the exception of propellant spray products [38]. The Scientific Committee on Consumer Safety (SCCS) has conducted a safety assessment of homosalate and has raised concerns about its endocrine-disrupting properties, recommending a maximum concentration of 1.4% in the final product [42].
The clinical assessment of the systemic absorption found maximum plasma concentrations over the 0.5 ng/mL threshold [39]. The observed concentrations were bigger than those observed for octisalate, probably because of its higher lipophilicity.

6. Cinnamic Acid Derivatives

Several esters of cinnamic acid derivatives are used as UVB absorbers and, due to their properties, are considered a better alternative to PABA derivatives [43]. The unsaturated bond between the aromatic ring and the carboxyl group improves the capacity for absorption in UV conditions [44]. The structures of representative cinnamic acid derivatives used as UV filters are presented in Figure 3.

6.1. Isopentyl 4-Methoxycinnamate

The isoamyl p-methoxycinnamte (INCI), also known as amiloxate (INN), is the ester of 4-methoxycinnamic acid with isopentanol [45]. The maximum absorption wavelength is 308 nm and the molar absorption coefficient is 24,355. Its use is approved in the EU, Australia, China, and India in all types of cosmetic products at concentrations up to 10%. It is not authorized in the US [43].

6.2. 2-Ethylhexyl 4-Methoxycinnamate

The 2-ethylhexyl ester of 4-methoxycinnamic acid, also referred to as octinoxate (INN), is structurally similar to octisalate and padimate O, all sharing the 2-ethylhexyl ester group [46]. It has a λmax of 311 nm and the value of ε is referenced as 23,300 mol−1 cm−1 [20]. In the EU, China, and Australia, the maximum allowed concentration is regulated as 10%, while in the US and Canada the concentration is 7.5%. In Japan, it is accepted as high as 20% [47]. The use of octinoxate-based products is banned in the state of Hawaii because of its toxic risks for the marine ecosystem [48].

6.3. Cinoxate

2-Ethoxyethyl 4-methoxycinnamate is the ester of 4-methoxycinnamic acid and 2-ethoxyethol. The values of the absorption peak (308 nm) and the molar absorptivity coefficient (20,650 mol−1 cm−1) are very similar to those for amiloxate and octinoxate [49]. The presence of the ethoxyethol fragment provides a considerably higher water solubility and lower lipophilicity compared with octinoxate. It is approved as a UV filter in the US, Canada, and Australia, but not in the EU [43].

6.4. Octocrylene

Chemically, it is the 2-ethylhexyl ester of 2-cyano-3,3-diphenylacrylic acid. It is approved in the EU and considered safe in various products such as creams, lotions, pump sprays, face or hand creams, and lipsticks, as long as the concentration does not exceed 10%. The concentration in propellant spray products is limited to 9% [50]. The chemical difference with the other cinnamate UV filters can be observed in the almost half ε value (12,290) for the 303 nm peak [20].
A study on 28 healthy volunteers indicated a significant plasma concentration after dermal exposure to a commercial sunscreen containing octocrylene [39].
In chlorination experiments, it was found to be stable even at high chlorine concentrations, while octinoxate was not [51,52]. The difference between the two cinnamic acid derivatives is probably due to the electron-withdrawing effect of the nitrile group on the double bond [51]. It is resistant to abiotic hydrolysis and photolysis and it is considered poorly biodegradable [51]. It has a good chemical stability and, correlated with its high lipophilicity, it has a persistence in sediments and a high bioaccumulation rate in organisms [52].
After a 6-week accelerated-stability aging test, several sunscreen products were examined. It was found that the products containing octocrylene exhibited concentrations of benzophenone ranging from 6 mg/kg to 186 mg/kg. The observed phenomenon is attributed to the slow retro-aldol condensation reaction of octocrylene, leading to the formation of benzophenone [53]. The health impact of these results is contested by several specialists [54,55].

7. Benzylidenecamphor Derivatives

The compounds in this class are α,β-unsaturated carbonyl compounds, relatively similar structurally to the cinnamic acid derivatives. The conjugated double bond system functions as a chromophore, but is also susceptible to Michael addition reactions that can lead skin toxicity.
After sunlight exposure, the photostability of these types of compounds was demonstrated, showing that their UV spectral profiles remained almost unchanged after irradiation. The UV absorption process for the camphor derivatives occurs through photo-induced reversible transcis isomerization [33]. The structures of representative camphor derivatives are presented in Figure 4.

7.1. 4-Methylbenzylidene Camphor

Enzacamene (USAN), also known as (4-MBC) or under its trade names Parsol 5000 or Eusolex 6300, chemical name 3-(4′-methylbenzylidene)-dl-camphor, is a UVB filter with a λmax of 300 nm [49] approved to be used up to 4% in Canada and the EU. It has a large molar absorption coefficient of 24,500 M−1 cm−1 at 300 nm [33]. Due to its perfect photostability, it was widely used in sunscreen between 1994 and 2006 [56].
Several studies revised by Ruszkiewicz and colleagues showed that this highly lipophilic compound is resorbed through the skin after dermal administration and it accumulates in plasma and urinary excretion [57].
Its endocrine-disrupting properties were thoroughly studied [58,59] and discussed by many researchers [6,60] so that the latest SCCS opinion decided that there is sufficient evidence that 4-MBC may act as an endocrine disruptor and has effects on both the thyroid and estrogen systems, but the effects on the androgen system are not so evident, as only in vitro evidence is available. However, the maximum concentration of 4% is not yet reduced, but the SCCS conclusion is that the use of 4-MBC at the maximum concentration of 4% in cosmetic ingredients would not be safe [61]. For the same reasons, its unmethylated derivate (3-benzylidene camphor) was banned for use in cosmetics products in 2018 [62].

7.2. Benzylidene Camphor Sulfonic Acid

Chemically, it can be viewed as a derivative of enzacamene where the methyl group was changed with a sulfonic acid, a moiety capable of forming salts. This UVB filter (λmax = 294 nm) [49] is chemically known as α-(2-oxoborn-3-ylidene)toluene-4-sulphonic acid. It can be used in the EU, Australia, and Japan up to 6% (as an acid). In addition to its acid form, its salts can also be used in sunscreen products [38,63]. Because it is considered a low-risk substance [64], it was not a priority for research.

7.3. Camphor Benzalkonium Methosulfate

This photostable [65] UVB filter (λmax = 284 nm, ε = 24,500) [49], chemically named N,N,N-trimethyl-4-(2-oxoborn-3-ylidenemethyl) anilinium methyl sulphate, and also known by the trade name Mexoryl SO, is approved for use in Australia and the EU up to 6% in sunscreen products [38,63]. In 2006, the Scientific Committee on Consumer Product (SCCP) requested a new dermal absorption study, but the applicant did not perform it, so in 2008 the SCCP recommended a reduction in the maximum concentration from 6% to 3% [66]. Regarding its safety for humans and the environment, according to Lodén and colleagues, it has no risk to the environment, and there were no data available for potential health risks or contact allergies [67].

7.4. Terephthalylidene Dicamphor Sulfonic Acid

This water-soluble UVA I filter (λmax = 345 nm, ε = 47,100), chemically named 3,3′-(1,4-phenylenedimethylene) bis (7,7-dimethyl-2-oxobicyclo-[2.2.1] hept-1-ylmethanesulfonic acid), also known as ecamsule, was developed and patented by L’Oreal in 1982 and has the trade name Mexoryl SX [68]. The higher peak value can be explained by the extended conjugated system as compared with the other camphor derivatives. Its use is approved worldwide, with the exception being the US (10% maximum concentration as an acid) [49]. Although the FDA needs more data to approve ecamsule [69] as a sunscreen ingredient, it can be found in some of the best-selling facial sunscreens online [70] and in the sunscreen “Anthelios SX”, which was approved by the FDA in 2006 [56].
Due to its absorption spectrum, this filter completed the exiting formulation enlarging the photoprotection domain, but cannot be used as a single ingredient. Regarding its photostability, some authors declare that ecamsule is photostable [71,72], but in a more recent study it was found to be very photo-unstable and photodegraded with the irradiation of UV light [73,74]. However, several studies showed that the addition of ecamsule increased the sunscreen’s efficacy and photostability [75,76]. Also, Fourtanier and colleagues made a review of clinical studies that were conducted until 2008 and concluded that the addition of ecamsule in sunscreens increased the efficacy of these products against a large number of biological damages induced by UVA, SSR, and sun exposure [77].

7.5. Polyacrylamidomethyl Benzylidene Camphor

This UVB filter (λmax = 297 nm, ε = 19,700) [49], chemically named as a polymer of N-{(2 and 4)-[(2-oxoborn-3-ylidene)methyl]benzyl}acrylamide, is approved in the EU to be used in sunscreens up to 6% [38]. It is commercialized under the trade name Mexoryl SW [78] and it is considered a non-phototoxic chemical [79]. Other properties of this compound have not been found and, because its polymeric nature, the predictions are not reliable [64].

8. Benzophenone Derivatives and Structural Analogs

The common scaffold is represented by two benzene rings connected by a carbonyl group. Additionally, they have an ortho substitution with a hydrogen-donor group and a para substitution with an electron-donating group [80]. The structures of the most important derivatives are presented in Figure 5.

8.1. Oxybenzone

Benzophenone-3 (BP-3), chemically known as 2-hydroxy-4-methoxybenzophenone, is commonly referred to as oxybenzone. It appears as a white to pale-yellow solid with a melting point around 66 °C. It absorbs in the UVB (280–315 nm) and short-wavelength UVA (315–355 nm) ranges and has been approved by the FDA since the 1980s. It is approved in the EU [81].
BP-3 is demonstrated to have some degree of skin absorption, although the extent of absorption can vary depending on various factors such as the concentration of BP-3 in the product [82]. The potential endocrine-disrupting effect of oxybenzone prompted the SCCS to perfume a safety assessment and recommend a maximum concentration of 2.2% in body creams, in propellants, and in pump sprays, and as 6% in face or hand cream and lipsticks [80].
Because of its highly lipophilic character, BP-3 exhibits slow biodegradation, a propensity to adsorb into suspended solids and sediments, and a low potential for volatilization from water surfaces [83].

8.2. Sulisobenzone

It is also named benzophenone-4 and it is the sulfonic acid derivative of oxybenzone; the chemical name is 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid. It has two peaks, at 286 nm and 440 nm, with molar absorptivity coefficients of 13,400 mol−1 cm−1 and 8400 mol−1 cm−1 [20]. It is approved in the EU as a UV filter in sunscreen products at a concentration up to 5%. Benzophenone-5 is the sodium salt of benzophenone-4 [6].

8.3. Dioxybenzone

It is also called benzophenone-8 (BP-8) or 2,2′-dihydroxy-4-methoxy benzophenone and it is chemically similar to BP-3. It is very similar structurally to BP-3, having one additional hydroxyl group. It is approved at concentrations up to 3% [82].

8.4. Hexyl 2-[4-(Diethylamino)-2-hydroxybenzoyl]benzoate

Diethylamino hydroxybenzoyl hexyl benzoate (DHHB) received approval in the EU in 2005 and demonstrated remarkable absorption capabilities within the UVA spectrum, with a peak absorption at 354 nm. It exhibits excellent photostability properties, ensuring its effectiveness over extended periods of sun exposure [82]. It is rapidly degraded in water, with the reaction rate being higher in the presence of active chlorine or at an acidic pH [84].

8.5. Bis-(diethylaminohydroxybenzoyl benzoyl) Piperazine (BDBP)

This compound, together with its nano form, referred to as HAA299, was added to Annex VI of Regulation No 1223/2009 in 2022. It can be used in nano form as well, with the maximum concentration allowed being 10% (either alone or combined with the nano form) [85]. BDBP absorbs between 350 and 425 nm; hence, it is a UVA1 filter, but this compound also has protective effects for visible light. Recently, it has been proven that visible light (385–405 nm) contributes to skin pigmentation. The addition of BDBP in a sunscreen product afforded significantly more protection against pigmentation in a study conducted on nine volunteers [86]. The UV absorption of HAA299 particles increases with decreasing particle size, leading to a significant advantage for HAA299 (nano) versus HAA299 (non-nano). Even in nano form, it is a practically insoluble material considered safe to be applied on the skin due to the very low dermal absorption. However, after acute inhalation exposure, it has caused inflammatory effects on the lungs. Therefore, the SCCS does not recommend the use of HAA299 (nano) in applications that could lead to the exposure of the consumer’s lungs via inhalation [85].

9. Dibenzoylmethane Derivatives

Avobenzone

Avobenzone, also known as butyl methoxydibenzoylmethane or chemically as 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione (Figure 6), is a highly effective UVA filter. It is recognized as one of the most prominent UVA filters due to its ability to absorb a wide range of UVA rays, especially the UVA I spectrum; the maximum absorption peak is at 357 nm (ε = 34,140 mol−1 cm−1). Adding avobenzone to a sunscreen formulation allows one to obtain broad-spectrum protection against UV radiation, hence its wide use in sunscreens.
It is approved to be used worldwide in maximum concentrations that vary from 3% in the US and Canada [87,88] to 5% in Australia and the EU [38,63].
Being oil-soluble and with a molecular weight less than 500 g/mol (310.4 g/mol), avobenzone has a good permeability through the skin varying from 1.8 ng/mL to 4.3 ng/mL [89]. However, the FDA considers that absorption does not equal risk, but further studies are needed in order to update the regulatory framework for sunscreens [90]. Its major drawback is its photodegradation. The keto-enol tautomerism is responsible for its instability. The enol form is planar, photostable, and absorbs in the UVA range (315–400 nm), while the keto form absorbs in the UVC range (200–280 nm) and is prone to degradation [91].
The research to combat the photodegradation of avobenzone is numerous. Gholap and colleagues [74] reviewed the strategies used for avobenzone stabilization and grouped them in three categories: the addition of antioxidants (e.g., diethyl hexyl syringylidenemalonate), the addition of stabilizers (e.g., bemotrizinol, diethylamino hydroxy benzoyl hexyl benzoate, octocrylene), or novel formulations such as inclusion complexes or carriers. In addition to those mentioned, Lionetti and colleagues [92] highlight the importance of avoidance formaldehyde donors or the association with metal ions as well as the importance of the solvent used (paraffin is bad, ethanol is good). On the other hand, the association with OMC contributes to the loss of UV protection because of the production of non-UV light-absorbing photoproducts [93]. Furthermore, avobenzone is incompatible with caprylic capric triglyceride, propylparaben, and butylhydroxytoluene [94].

10. Benzimidazole and Benzotriazole Derivatives

10.1. Phenylbenzimidazole Sulfonic Acid

It is frequently referred to as ensulizole (USAN), while its chemical name is 2-phenylbenzimidazole-5-sulphonic acid (PBSA). The chemical structure is presented in Figure 7, along similar derivatives. It is used worldwide as a UVB filter (absorption peak 310 nm). The acid form has poor water solubility, but it can be increased by transforming into the corresponding salts with sodium hydroxide, potassium hydroxide, or with triethylamine (TEA) [95]. In the EU, it can be used at concentrations up to 8% (expressed as an acid), but in the US, Canada, and Australia the maximum concentration is 4% [38,63,87,88,96]. The study of PBSA’s effect on DNA showed that ensulizole protected against the formation of cyclobutane pyrimidine dimers after UVB exposure, but photosensitized the formation of oxidized guanine after UVA or UVB irradiation even at 4 mM, which is a very low concentration as compared with the 147 mM authorized by the FDA [97].
The season, the latitude, and also the weather can influence photodegradation rates [98]. Due to its photo-oxidizing properties, PBSA’s usefulness in sunscreen products can be questionable. The formation of free radicals can be inhibited by complexation with cyclodextrin [99], and its protective effect can be increased via incorporation in chitosan microparticles [100] or carboxymethyl chitosan and carboxymethyl-cellulose carriers [101].

10.2. Disodium Phenyl Dibenzimidazole Tetrasulfonate

It is also known as bisdisulizole disodium (USAN). Chemically, it can be viewed as a dimer analog of ensulizole. This UVA II filter, with a peak absorbance at 335 nm, was developed by Symrise (Holzminden, Germany), trade name Neo Heliopan® AP, [102] and it has been approved in the EU [38] since 2000 and in Australia [63] since 2005, with a maximum concentration of 10%. In the US [103] and Canada [87], it is not approved yet. Because it is a hydrophilic compound with a big molecular weight (674.57 g/mol), it has a very low skin penetration (around 1% of the dose applied) [104]; therefore, it has a good safety profile.

10.3. Drometrizole Trisiloxane

It has a 2-(2-hydroxyphenyl)-2H-benzotriazole scaffold common with a large class of ultraviolet stabilizers used especially for plastic materials [105]. The phenolic hydroxyl is essential for the optic properties of the compound by forming an intramolecular hydrogen bond with the nitrogen atom in the benzotriazole ring [106]. It presents two peaks, at 303 nm and 341 nm, with molar absorptivity coefficients of 16,200 mol−1 cm−1 and 15,500 mol−1 cm−1 [20]. The siloxane moiety makes it compatible with silicon oils that can be used as solvents for cosmetics [107].
It is a lipophilic derivative and is marketed as Meroxyl XL by L’Oreal (Clichy, France), currently being used almost worldwide, with the exception of the US [108], where the FDA considers that it needs additional data to recognize it as safe and effective [109]. In the EU and Canada, drometrizole trisiloxane (DTS) can be used in concentrations up to 15% [38,87], but in Australia the maximum concentration allowed is 10% [63]. The photostability and broad protection spectrum, UVB and UVA, are its biggest advantages. After being exposed to acidic, basic, photolytic, oxidative, and thermal conditions in order to determine its stability, it has been shown that extensive degradation is obtained after acid and base hydrolysis, but not from photolytic stress [110].
A study conducted on 1082 patients between 2004 and 2006 on a commercial sunscreen containing DTS produced only five relevant reactions, concluding that DTS is not a common allergenic. The presence of an allergic reaction to the commercial product without an allergic reaction to octocrylene was considered positive for DTS. Two out of these five patients were tested with 5% DTS in petrolatum, and both presented a reaction at the photo-irradiated sites [111].

10.4. Methylene Bis-benzotriazolyl Tetramethylbutylphenol

Its structure comprises a 2-(2-hydroxyphenyl)-2H-benzotriazole scaffold bond together with a methylene group.
It is a broad-spectrum UV filter, also known as bisoctrizole (INN) or MBBT, and is used in the EU and Australia at concentrations up to 10% [38,63], while in Canada only in combinations with a maximum concentration of 5% [87]. The combination of MBBT, water, decyl glucoside, propylene glycol, and xanthan gum has the trade name Tinosorb® M and is produced by BASF (Ludwigshafen, Germany). Its uniqueness is the micro-fine organic particle technology, the mixture being dispersible in water, soluble in polar cosmetic oils at 25 °C [112], functioning as a chemical filter, but also has a fraction of the solid particles, with insolubility increasing the photoprotection by scattering [113].
Data regarding its safety are still needed. The currently available scientific evidence shows an overall very low dermal absorption of MBBT in nano- or larger particle forms; therefore, the SCCS’s opinion is that MBBT at concentrations up to 10% is considered to not pose a risk of adverse effects in humans after application on healthy, intact skin [112]. The literature reported some allergic contact dermatitis cases after topical application of sunscreen products containing Tinosorb® M, but the allergen was proved to be decyl glucoside, not MBBT [114,115,116]. An in vitro study showed that this compound does not possess intrinsic estrogenic/antiestrogenic or androgenic/antiandrogenic activity [117].

11. Triazine Derivatives

The analysis of the pharmaceutical development process for agents applied topically argued that the molecular weight of a compound should be under 500 g/mol in order to be absorbed through the skin [118]. The compounds in this class share a triazine ring and a high molecular weight (Figure 8). All compounds detailed here are approved in the EU, three are approved in Austraila (ethylhexyl triazone, bemotrizinol, and tris-biphenyl triazine), and only bemotrizinol is approved in Canada, but none are approved in the US [38,63,87,88]. They do not have skin penetration and, subsequently, the adverse reactions. Until now, they have been considered safe, but more studies are needed [37].

11.1. Ethylhexyl Triazone

The compound’s chemical name is 2,4,6-trianilino-(p-carbo-2′-ethylhexyl-1′-oxy)-1,3,5-triazine. It has a central triazine ring that acts like a linker for three 2-ethylhexyl 4-aminobenzoate fragments. Because of this, it is very similar structurally to padimate O. It has a very similar peak wavelength (314 nm), but a higher absorbance capacity due to the presence of three chromophore groups [20]. The name ethylhexyl triazone (EHT) can be confusing, because chemically it is a triazine derivative, and not a triazone.
This UVB filter can be used in sunscreen formulations at a maximum concentration of 5% [38,63]. In addition to its effective protective action against UV radiation, it also has good photostability [27] and low skin penetration [119], but it is practically insoluble in water. Therefore, obtaining oil-free formulations is almost impossible [120]. Even though it is oil-soluble, it is frequently used in sunscreen products, with 38% frequency in sunscreens for adults and almost 45% in sunscreens for children [27]. Due to all the advantages, new delivery systems have been developed, such as encapsulation in lipid microparticles [120] or nanostructured lipid carriers [121,122].

11.2. Diethylhexyl Butamido Triazone

The chemical name is benzoic acid, 4,4-{[6-[[[(1,1-dimethylethyl)amino]carbonyl]phenyl]amino]-1,3-5-triazine-2,4-diyl]diimino}bis-, bis(2-ethylhexyl)ester, but it is frequently referred to as iscotrizinol or DEBT. It has a similar chemical structure to ethylhexyl triazone, differing in the substitution of an ethylhexyl ester moiety with a t-butyl amide fragment.
This UVB filter, approved to be used up to 10% in the EU and up to 5% in Japan, is considered one of the most photostable filters available on the market [123]. It has great oil solubility [124]; thus, it can be added in the oil phase of an oil–water (O/W) emulsion. It has anti-inflammatory properties similar to those of ketoprofen [125]. According to the SCCS opinion from 1998, it has an excellent safety profile, with low percutaneous absorption and no capacity to produce skin irritation, photo-irritation or photosensitization, photo-mutagenicity, or photo-clastogenicity. Even more, it has been found to be a non-irritant and hypoallergenic [126].

11.3. Bis-ethylhexyloxyphenol Methoxyphenyl Triazine

The chemical name is 2,4-bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-(1,3,5)-triazine, but it is usually cited as bemotrizinol (USAN), anisotriazine, or, shortly, BEMT.
It is an oil-soluble broad-spectrum UV filter [127] approved to be used up to 10% in the EU and Australia and only up to 6% in Canada [38,63,87]. It has also low skin penetration [119], even lower when it is incorporated in nanostructured lipid carriers, without losing its photostability [128]. Due to high photoprotective effectiveness and photostability, the usage frequency of BEMT almost doubled between 2015 and 2021 [27]. Similar to EHT, a water-dispersible inclusion complex has been developed, in this case being observed as a shift of the maximum absorption from 380 nm to 345 nm for the inclusion complex [127], meaning a loss in UVA protection. The latest SCCS opinion is from 1999, where there was no evidence of any kind of toxicity or allergenicity [129].

11.4. Tris-biphenyl Triazine

Chemically, it is 2,4,6-tri([1,1′-biphenyl]-4-yl)-1,3,5-triazine (TBPT). It differs from ethylhexyl triazone due to the substitution of the PABA ester moieties with biphenyl fragments.
This very efficient filter in both UVB and UVA regions was added to Annex VI of the Cosmetics Regulation (EC) No. 1223/2009 of the European Parliament and of the Council in 2016 and the maximum concentration allowed is 10%. In addition to its effectiveness, it is also very photostable [130]. Thus, it is used as well as a photo-stabilizer [131] for avobenzone. The nano form allowed to be used in sunscreen formulations must have: a median primary particle size >80 nm; a purity ≥ 98%; and must be uncoated. Also, this form must not be used in sprays [38]. Due to its molecular weight and polarity, this compound exceeds the limits where skin absorption is expected. Also, as a nanomaterial, it can be considered an insoluble substance, which means the balance between (bio)availability and safety goes to safety [132].

11.5. Phenylene Bis-diphenyltriazine

It is also cited by its chemical name, 3,3′-(1,4-phenylene)bis(5,6-diphenyl-1,2,4-triazine). This broad-spectrum filter is considered safe for use at a concentration up to 5% by the SCCS, but it should not be used in products that may lead to lung exposure [133]. As well as the other triazine derivates, this one can offer protection against UVB and all UVA rays, but its particularity is that it can protect also against blue light [134]. This heterocyclic compound, bearing a triazine scaffold in which three carbon-hydrogen units of the benzene ring are replaced by nitrogen atoms, is a chromophore for sunlight. Being insoluble and with a particle size outside the nano domain, its penetration rate through the skin is predicted to be low, hence its very low toxicity. Among the other qualities, it is photostable and has cellular protective properties [135]. Therefore, we expect this compound to be used more and more in sunscreen formulations and, of course, in research.

12. Other Compounds

12.1. Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate

For simplicity, this is commonly referred to as MCE or by the commercial name, Mexoryl 400. Chemically, the compound belongs to the class of cyclic merocyanines, a class characterized by high absorption coefficients (Figure 9). The UV-filtering mechanism is explained by the transfer of charge from the amino group to the ketone group through the polyene chain [136]. This new UVA1 filter exhibiting a peak of absorption at 385 nm was approved by the SCCS for use in sunscreen products up to 3% in 2020, but not in applications that may lead to exposure of the end-user’s lungs via inhalation [38].
Several recent clinical trials conducted by L’Oréal employees evaluated the photoprotection afforded by the sunscreen formulas containing MCE. In an initial study, a trial was performed on 19 volunteers using a monocentric, double-blinded, randomized comparative approach. The results demonstrated that the addition of MCE (the name of the substance) prolonged the range of absorption up to 400 nm. Additionally, it was found to diminish the adverse effects caused by UVA1 radiation on the skin, including alterations at the cellular, biochemical, and molecular levels. Moreover, the inclusion of MCE was observed to reduce UVA1-induced pigmentation [137]. Three other studies revealed that incorporating MCE into sunscreen products, specifically targeting longer UVA1 wavelengths, resulted in a more effective prevention of hyperpigmentation compared with standard products. Notably, no associated side effects were observed [138]. Lastly, another study proved that there is no significant difference between the photoprotective efficacy of 1%, 1.5%, and 2% MCE, concluding that 1% MCE suffices to reach the highest level of efficacy [139].

12.2. Polysilicone-15

It is also known as dimethicodiethylbenzalmalonate. It can be considered a derivative of cinnamic acid. It is made of diethyl benzylidenemalonate, which functions as chromophores attached to a polysiloxane chain. It has an average molecular weight over 6000 g/mol; therefore, it has low skin permeability [18].
It is a UVB filter approved in the EU and Australia for use in sunscreen formulations at a concentration up to 10% [38,63]. Its SPF, measured in vitro, had a low value (3.64), with a peak absorbance at 312 nm [140]. Thus, it needs to be combined with a UVA filter. The combination with avobenzone not only increases the spectrum, but polysilicone-15 is also a good stabilizer for avobenzone [92].

12.3. Meradimate

This compound, also known as menthyl anthranilate, is a UVA II filter approved to be used at concentrations up to 5% in the US, Australia, and Canada [63,87,88], but not in the EU [38]. Some authors mistakenly consider meradimate as “methyl anthranilate”, probably because of the one-letter difference. Chemically, it is similar to the PABA derivatives, but their optical properties are significantly different because of the electronic effects and hydrogen intramolecular bond of the ortho amino substitution [20].
Meradimate is utilized in various products, like lip balms, lipsticks, and moisturizers, due to its ability to filter both UVA and UVB radiation. Even if it is considered an agent with a broad spectrum of protection, its coverage of UVA rays is limited, extending only up to 336 nm. Despite having a theoretical protective range between 200 and 380 nm, empirical evidence confirms this limitation [141,142].

13. Organic versus Inorganic UV Protection

The discussion of mineral filters is beyond the scope of this review, but it is important to highlight the main difference between these two main categories in order to better understand the advantages and the drawbacks of organic filters. Both zinc oxide and titanium dioxide are approved and widely used as active ingredients in sunscreen products [37,41]. Titanium dioxide is the most frequently used inorganic UV filter due to its photo- and chemical stability. Although it has been included in Annex VI of Regulation No 1223/2009 since 2019, the nano form is much more often found in adult sunscreen products than the micro form, probably because of its more discreet appearance on the skin. The nano-sized titanium dioxide induces lower skin irritability than most organic sunscreens and is less photoreactive [17,143]. However, when titanium dioxide nanoparticles are exposed to UV radiation, there is a possibility of generating reactive oxygen species (ROS) as a result of a photochemical reaction, leading to potential adverse effects [144]. Zinc oxide is the other inorganic UV filter included by the European Commission in Annex VI, with its both nano and non-nano forms [145].
The human health risks with inorganic filters are considered to be low given a lack of percutaneous absorption; however, there is potential risk when exposed via inhalation, prompting recommendations against spray sunscreen products. The known risk to the environment is low, though the risk stratification may evolve with increasing usage of these filters and higher environmental concentrations [146].

14. Conclusions

The UV filters play a crucial role in reducing the risk of various skin disorders, including sunburn, skin aging, and cancer. This review has provided an overview of organic UV filters as active ingredients in sunscreen products, highlighting their classification and structural characteristics. Despite their important advantages, the mineral filters leave a white or chalky residue on the skin, which may be cosmetically undesirable for some individuals and, in general, result in lower SPF values compared with most organic filters, requiring frequent reapplication, highlighting the significance of organic UV filters.
In summary, this review has provided valuable insights into the main classes of organic UV filters by examining factors like photostability, mechanisms of action, optical properties, and regulatory status in relation to their chemical structure. This knowledge contributes to a better understanding of sunscreen technology and emphasizes the importance of ongoing research in the development of new UV filters. The pursuit of new UV filters through research is crucial for advancing sunscreen technology and ensuring the availability of effective and safe options for sun protection.

Funding

This article was published with the support granted by the project entitled “Net4SCIENCE: Applied doctoral and postdoctoral research network in the fields of smart specialization Health and Bioeconomy”, project code POCU/993/6/1/154722.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Fivenson, D.; Sabzevari, N.; Qiblawi, S.; Blitz, J.; Norton, B.B.; Norton, S.A. Sunscreens: UV filters to protect us: Part 2-Increasing awareness of UV filters and their potential toxicities to us and our environment. Int. J. Women’s Dermatol. 2021, 7, 45–69. [Google Scholar] [CrossRef] [PubMed]
  2. Guan, L.L.; Lim, H.W.; Mohammad, T.F. Sunscreens and Photoaging: A Review of Current Literature. Am. J. Clin. Dermatol. 2021, 22, 819–828. [Google Scholar] [CrossRef] [PubMed]
  3. Geoffrey, K.; Mwangi, A.N.; Maru, S.M. Sunscreen products: Rationale for use, formulation development and regulatory considerations. Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc. 2019, 27, 1009–1018. [Google Scholar] [CrossRef] [PubMed]
  4. Ngoc, L.T.; Tran, V.V.; Moon, J.-Y.; Chae, M.; Park, D.; Lee, Y.-C. Recent Trends of Sunscreen Cosmetic: An Update Review. Cosmetics 2019, 6, 64. [Google Scholar] [CrossRef] [Green Version]
  5. Jesus, A.; Sousa, E.; Cruz, M.T.; Cidade, H.; Lobo, J.M.S.; Almeida, I.F. UV Filters: Challenges and Prospects. Pharmaceuticals 2022, 15, 263. [Google Scholar] [CrossRef]
  6. Egambaram, O.P.; Kesavan Pillai, S.; Ray, S.S. Materials Science Challenges in Skin UV Protection: A Review. Photochem. Photobiol. 2020, 96, 779–797. [Google Scholar] [CrossRef] [Green Version]
  7. Singer, S.; Karrer, S.; Berneburg, M. Modern sun protection. Curr. Opin. Pharmacol. 2019, 46, 24–28. [Google Scholar] [CrossRef]
  8. Johnson, B.C.; Yoon, H.; Rice, J.P.; Parr, A.C. Chapter 1.2—Principles of Optical Radiometry and Measurement Uncertainty. In Optical Radiometry for Ocean Climate Measurements; Zibordi, G., Donlon, C.J., Parr, A.C., Eds.; Academic Press: Cambridge, MA, USA, 2014; Volume 47, pp. 13–67. [Google Scholar]
  9. Bernerd, F.; Passeron, T.; Castiel, I.; Marionnet, C. The Damaging Effects of Long UVA (UVA1) Rays: A Major Challenge to Preserve Skin Health and Integrity. Int. J. Mol. Sci. 2022, 23, 8243. [Google Scholar] [CrossRef]
  10. Kimlin, M.G. Geographic location and vitamin D synthesis. Mol. Aspects Med. 2008, 29, 453–461. [Google Scholar] [CrossRef]
  11. Heckman, C.J.; Chandler, R.; Kloss, J.D.; Benson, A.; Rooney, D.; Munshi, T.; Darlow, S.D.; Perlis, C.; Manne, S.L.; Oslin, D.W. Minimal Erythema Dose (MED) testing. J. Vis. Exp. 2013, 75, e50175. [Google Scholar]
  12. Shin, D.W. Various biological effects of solar radiation on skin and their mechanisms: Implications for phototherapy. Anim. Cells Syst. 2020, 24, 181–188. [Google Scholar] [CrossRef] [PubMed]
  13. Polefka, T.G.; Meyer, T.A.; Agin, P.P.; Bianchini, R.J. Effects of solar radiation on the skin. J. Cosmet. Dermatol. 2012, 11, 134–143. [Google Scholar] [CrossRef] [PubMed]
  14. Dominguez, L.J.; Farruggia, M.; Veronese, N.; Barbagallo, M. Vitamin D Sources, Metabolism, and Deficiency: Available Compounds and Guidelines for Its Treatment. Metabolites 2021, 11, 255. [Google Scholar] [CrossRef] [PubMed]
  15. Geisler, A.N.; Austin, E.; Nguyen, J.; Hamzavi, I.; Jagdeo, J.; Lim, H.W. Visible light. Part II: Photoprotection against visible and ultraviolet light. J. Am. Acad. Dermatol. 2021, 84, 1233–1244. [Google Scholar] [CrossRef] [PubMed]
  16. Mansour, O.T.; Venero, D.A. Insights into the structure of sunscreen lotions: A small-angle neutron scattering study. RSC Adv. 2021, 11, 14306–14313. [Google Scholar] [CrossRef]
  17. Yuan, S.; Huang, J.; Jiang, X.; Huang, Y.; Zhu, X.; Cai, Z. Environmental Fate and Toxicity of Sunscreen-Derived Inorganic Ultraviolet Filters in Aquatic Environments: A Review. Nanomaterials 2022, 12, 699. [Google Scholar] [CrossRef]
  18. Daly, S.; Ouyang, H.; Maitra, P. Chemistry of sunscreens. In Principles and Practice of Photoprotection; Springer International Publishing: Cham, Switzerland, 2016; pp. 159–178. [Google Scholar]
  19. Tovar-Sánchez, A.; Sparaventi, E.; Gaudron, A.; Rodríguez-Romero, A. A new approach for the determination of sunscreen levels in seawater by ultraviolet absorption spectrophotometry. PLoS ONE 2020, 15, e0243591. [Google Scholar] [CrossRef]
  20. Shaath, N.A. The chemistry of ultraviolet filters. In Principles and Practice of Photoprotection; Springer International Publishing: Cham, Switzerland, 2016; pp. 143–157. [Google Scholar]
  21. Savoca, D.; Pace, A. Bioaccumulation, Biodistribution, Toxicology and Biomonitoring of Organofluorine Compounds in Aquatic Organisms. Int. J. Mol. Sci. 2021, 22, 6276. [Google Scholar] [CrossRef]
  22. Taylor, C.R.; Stern, R.S.; Leyden, J.J.; Gilchrest, B.A. Photoaging/photodamage and photoprotection. J. Am. Acad. Dermatol. 1990, 22, 1–15. [Google Scholar] [CrossRef]
  23. Kaidbey, K.H.; Kligman, A.M. Phototoxicity to a Sunscreen Ingredient: Padimate A. Arch. Dermatol. 1978, 114, 547–549. [Google Scholar] [CrossRef]
  24. Svarc, F. A brief illustrated history on sunscreens and sun protection. Pure Appl. Chem. 2015, 87, 929–936. [Google Scholar] [CrossRef]
  25. Bruze, M.; Gruvberger, B.; Thune, P. Contact and photocontact allergy to glyceryl para-aminobenzoate. Photo-Dermatology 1988, 5, 162–165. [Google Scholar] [PubMed]
  26. Bhattacharjee, D.; S, P.; Patil, A.B.; Jain, V. A comparison of Natural and Synthetic Sunscreen Agents: A Review. Int. J. Pharm. Res. 2021, 13, 3494–3505. [Google Scholar]
  27. Jesus, A.; Augusto, I.; Duarte, J.; Sousa, E.; Cidade, H.; Cruz, M.T.; Lobo, J.M.S.; Almeida, I.F. Recent Trends on UV filters. Appl. Sci. 2022, 12, 12003. [Google Scholar] [CrossRef]
  28. Pantelic, M.N.; Wong, N.; Kwa, M.; Lim, H.W. Ultraviolet filters in the United States and European Union: A review of safety and implications for the future of US sunscreens. J. Am. Acad. Dermatol. 2023, 88, 632–646. [Google Scholar] [CrossRef] [PubMed]
  29. Gadgil, V.R.; Darak, A.; Patil, S.J.; Chopada, A.; Kulkarni, R.A.; Patil, S.M.; Gupta, N.A.; Mehta, T.N.; Joshi, S.V. Recent developments in chemistry of sunscreens & their photostabilization. J. Indian Chem. Soc. 2023, 100, 100858. [Google Scholar]
  30. Tarras-Wahlberg, N.; Stenhagen, G.; Larkö, O.; Rosén, A.; Wennberg, A.M.; Wennerström, O. Changes in ultraviolet absorption of sunscreens after ultraviolet irradiation. J. Investig. Dermatol. 1999, 113, 547–553. [Google Scholar] [CrossRef] [Green Version]
  31. Sung, C.R.; Kim, K.-B.; Lee, J.Y.; Lee, B.-M.; Kwack, S.J. Risk Assessment of Ethylhexyl Dimethyl PABA in Cosmetics. Toxicol. Res. 2019, 35, 131–136. [Google Scholar] [CrossRef] [Green Version]
  32. Urbach, F. The historical aspects of sunscreens. J. Photochem. Photobiol. B Biol. 2001, 64, 99–104. [Google Scholar] [CrossRef]
  33. Cantrell, A.; McGarvey, D.J.; Truscott, T.G. Chapter 26—Photochemical and photophysical properties of sunscreens. In Sun Protection in Man; Giacomoni, P.U., Ed.; Elsevier: Amsterdam, The Netherlands, 2001; Volume 3, pp. 495–519. [Google Scholar]
  34. Serpone, N. Sunscreens and their usefulness: Have we made any progress in the last two decades? Photochem. Photobiol. Sci. 2021, 20, 189–244. [Google Scholar] [CrossRef]
  35. Mori, S.; Wang, S.Q. 50—Sunscreens. In Comprehensive Dermatologic Drug Therapy; Wolverton, S.E., Fourth, E., Eds.; Elsevier: Amsterdam, The Netherlands, 2021; pp. 565–575.e2. [Google Scholar]
  36. Holt, E.L.; Krokidi, K.M.; Turner, M.A.P.; Mishra, P.; Zwier, T.S.; Rodrigues, N.D.N.; Stavros, V.G. Insights into the photoprotection mechanism of the UV filter homosalate. Phys. Chem. Chem. Phys. 2020, 22, 15509–15519. [Google Scholar] [CrossRef] [PubMed]
  37. Santander Ballestín, S.; Luesma Bartolomé, M.J. Toxicity of Different Chemical Components in Sun Cream Filters and Their Impact on Human Health: A Review. Appl. Sci. 2023, 13, 712. [Google Scholar] [CrossRef]
  38. Cosmetics Directive. Allowed UV Filters: Annex VI, Regulation 1223/2009/EC on Cosmetic Products, as Amended by Regulation (EU) 2022/2195, OJ L 292; Publication Office of the European Union: Luxembourg, 2022.
  39. Matta, M.K.; Florian, J.; Zusterzeel, R.; Pilli, N.R.; Patel, V.; Volpe, D.A.; Yang, Y.; Oh, L.; Bashaw, E.; Zineh, I.; et al. Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. JAMA 2020, 323, 256–267. [Google Scholar] [CrossRef] [PubMed]
  40. Sabzevari, N.; Qiblawi, S.; Norton, S.A.; Fivenson, D. Sunscreens: UV filters to protect us: Part 1: Changing regulations and choices for optimal sun protection. Int. J. Women’s Dermatol. 2021, 7, 28–44. [Google Scholar] [CrossRef]
  41. Bode, A.M.; Roh, E. Are FDA-Approved Sunscreen Components Effective in Preventing Solar UV-Induced Skin Cancer? Cells 2020, 9, 1674. [Google Scholar] [CrossRef] [PubMed]
  42. Scientific Committee on Consumer Safety (SCCS). Scientific Advice on the Safety of Homosalate (CAS No 118-56-9, EC No 204-260-8) as a UV-Filter in Cosmetic Products; European Union: Luxembourg, 2021. [Google Scholar]
  43. Gunia-Krzyżak, A.; Słoczyńska, K.; Popiół, J.; Koczurkiewicz, P.; Marona, H.; Pękala, E. Cinnamic acid derivatives in cosmetics: Current use and future prospects. Int. J. Cosmet. Sci. 2018, 40, 356–366. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Wang, J.; Pan, L.; Wu, S.; Lu, L.; Xu, Y.; Zhu, Y.; Guo, M.; Zhuang, S. Recent Advances on Endocrine Disrupting Effects of UV Filters. Int. J. Environ. Res. Public Health 2016, 13, 782. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Tampucci, S.; Burgalassi, S.; Chetoni, P.; Monti, D. Cutaneous Permeation and Penetration of Sunscreens: Formulation Strategies and In Vitro Methods. Cosmetics 2018, 5, 1. [Google Scholar] [CrossRef] [Green Version]
  46. Herzog, B.; Amorós-Galicia, L.; Sohn, M.; Hofer, M.; Quass, K.; Giesinger, J. Analysis of photokinetics of 2′-ethylhexyl-4-methoxycinnamate in sunscreens. Photochem. Photobiol. Sci. 2019, 18, 1773–1781. [Google Scholar] [CrossRef]
  47. Stiefel, C.; Schwack, W. Photoprotection in changing times—UV filter efficacy and safety, sensitization processes and regulatory aspects. Int. J. Cosmet. Sci. 2015, 37, 2–30. [Google Scholar] [CrossRef] [Green Version]
  48. Suh, S.; Pham, C.; Smith, J.; Mesinkovska, N.A. The banned sunscreen ingredients and their impact on human health: A systematic review. Int. J. Dermatol. 2020, 59, 1033–1042. [Google Scholar] [CrossRef] [PubMed]
  49. Shaath, N.A. Ultraviolet filters. Photochem. Photobiol. Sci. 2010, 9, 464–469. [Google Scholar] [CrossRef]
  50. European Commission, Directorate-General for Health and Food Safety. Opinion on Octocrylene; Publications Office of the European Union: Luxembourg, 2021. [Google Scholar] [CrossRef]
  51. Duis, K.; Junker, T.; Coors, A. Review of the environmental fate and effects of two UV filter substances used in cosmetic products. Sci. Total Environ. 2022, 808, 151931. [Google Scholar] [CrossRef] [PubMed]
  52. Manasfi, T.; Coulomb, B.; Ravier, S.; Boudenne, J.-L. Degradation of Organic UV filters in Chlorinated Seawater Swimming Pools: Transformation Pathways and Bromoform Formation. Environ. Sci. Technol. 2017, 51, 13580–13591. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Downs, C.A.; DiNardo, J.C.; Stien, D.; Rodrigues, A.M.S.; Lebaron, P. Benzophenone Accumulates over Time from the Degradation of Octocrylene in Commercial Sunscreen Products. Chem. Res. Toxicol. 2021, 34, 1046–1054. [Google Scholar] [CrossRef]
  54. Howard, L.; Birnie, A.; Sarkany, R. Comment on Benzophenone Accumulates over Time from the Degradation of Octocrylene in Commercial Sunscreen Products. Chem. Res. Toxicol. 2021, 34, 1944–1945. [Google Scholar] [CrossRef]
  55. Surber, C. Letter to the Editor Regarding Benzophenone Accumulates over Time from the Degradation of Octocrylene in Commercial Sunscreen Products. Chem. Res. Toxicol. 2021, 34, 1935–1937. [Google Scholar] [CrossRef]
  56. Pavlou, P.; Siamidi, A.; Vlachou, M.; Varvaresou, A. UV filters and their distribution on the skin through safe. Non-penetrating vehicles. J. Cosmet. Sci. 2021, 72, 298–324. [Google Scholar]
  57. Ruszkiewicz, J.A.; Pinkas, A.; Ferrer, B.; Peres, T.V.; Tsatsakis, A.; Aschner, M. Neurotoxic effect of active ingredients in sunscreen products, a contemporary review. Toxicol. Rep. 2017, 4, 245–259. [Google Scholar] [CrossRef]
  58. 4-Methylbenzylidene-Camphor (4MBC) Causes Pituitary Effects Comparable to Hypothyroidism|ECE2006|8th European Congress of Endocrinology Incorporating the British Endocrine Societies|Endocrine Abstracts. Available online: https://www.endocrine-abstracts.org/ea/0011/ea0011oc60 (accessed on 6 June 2023).
  59. Quintaneiro, C.; Teixeira, B.; Benedé, J.L.; Chisvert, A.; Soares, A.M.V.M.; Monteiro, M.S. Toxicity effects of the organic UV-filter 4-Methylbenzylidene camphor in zebrafish embryos. Chemosphere 2019, 218, 273–281. [Google Scholar] [CrossRef]
  60. Matouskova, K.; Vandenberg, L.N. UV screening chemicals. In Reproductive and Developmental Toxicology; Elsevier: Amsterdam, The Netherlands, 2022; pp. 911–930. [Google Scholar]
  61. Scientific Committee on Consumer Products SCCP. OPINION on 4-Methylbenzylidene Camphor (4-MBC); European Union: Luxembourg, 2022. [Google Scholar]
  62. Commission Implementing Decision (EU) 2018/2013 on the Identification of 1,7,7-Trimethyl-3-(phenylmethylene)bicyclo [2.2.1]heptan-2-one (3-benzylidene camphor) as a Substance of Very High Concern Pursuant to Article 57(f) of Regulation (EC) No 1907/2006. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32018D2013 (accessed on 6 June 2023).
  63. Australian Regulatory Guidelines for Sunscreens (ARGS)|Therapeutic Goods Administration (TGA). Available online: https://www.tga.gov.au/resources/resource/guidance/australian-regulatory-guidelines-sunscreens-args (accessed on 2 June 2023).
  64. Brooke, D.; Burns, J.S.; Agency, G.B.E.; Crookes, M.J. UV-Filters in Cosmetics: Prioritisation for Environmental Assessment; Environment Agency Science Report; Environment Agency: Bristol, UK, 2008. [Google Scholar]
  65. FC172206|52793-97-2|Camphor Benzalkonium Methosulfate. Available online: https://www.biosynth.com/p/FC172206/52793-97-2-camphor-benzalkonium-methosulfate (accessed on 6 June 2023).
  66. Scientific Committee on Consumer Products SCCP. Opinion on Camphor Benzalkonium Methosulfate COLIPA n° S57; European Union: Luxembourg, 2009. [Google Scholar]
  67. Lodén, M.; Beitner, H.; Gonzalez, H.; Edström, D.W.; Åkerström, U.; Austad, J.; Buraczewska-Norin, I.; Matsson, M.; Wulf, H.C. Sunscreen use: Controversies, challenges and regulatory aspects. Br. J. Dermatol. 2011, 165, 255–262. [Google Scholar] [CrossRef] [PubMed]
  68. Mexoryl SX—Ingredient|Inside Our Products—L’Oréal. Available online: https://inside-our-products.loreal.com/ingredients/mexorylr-sx (accessed on 5 June 2023).
  69. Federal Register: Over-the-Counter Sunscreen Drug Products-Regulatory Status of Ecamsule. Available online: https://www.federalregister.gov/documents/2015/02/25/2015-03883/over-the-counter-sunscreen-drug-products-regulatory-status-of-ecamsule (accessed on 5 June 2023).
  70. Su, J.J.; Ward, J.M.; Moon, J.Y.; Mayur, O.N.; Davis, L.S. New Sunscreens on the Block: Evaluation of the Online Sunscreen Market in the United States. Dermatitis 2022. [Google Scholar] [CrossRef] [PubMed]
  71. UVA: Grasping A Better Understanding of This Formidable Opponent. Dermatologist. 2007. Available online: https://www.hmpgloballearningnetwork.com/site/thederm/article/7445 (accessed on 3 June 2023).
  72. Linder, J. The science behind sunscreens. Plast. Surg. Nurs. 2012, 32, 129–131. [Google Scholar] [CrossRef] [PubMed]
  73. Abid, A.R.; Marciniak, B.; Pędziński, T.; Shahid, M. Photo-stability and photo-sensitizing characterization of selected sunscreens’ ingredients. J. Photochem. Photobiol. A Chem. 2017, 332, 241–250. [Google Scholar] [CrossRef]
  74. Gholap, A.D.; Sayyad, S.F.; Hatvate, N.T.; Dhumal, V.V.; Pardeshi, S.R.; Chavda, V.P.; Vora, L.K. Drug Delivery Strategies for Avobenzone: A Case Study of Photostabilization. Pharmaceutics 2023, 15, 1008. [Google Scholar] [CrossRef] [PubMed]
  75. L’Alloret, F.; Candau, D.; Seité, S.; Pygmalion, M.J.; Ruiz, L.; Josso, M.; Meaudre, H.; Gauchet, L.; Pena, A.M.; Colonna, A. New combination of ultraviolet absorbers in an oily emollient increases sunscreen efficacy and photostability. Dermatol. Ther. 2012, 2, 4. [Google Scholar] [CrossRef] [Green Version]
  76. DeLeo, V.A.; Clark, S.; Fowler, J.; Poncet, M.; Loesche, C.; Soto, P. A new ecamsule-containing SPF 40 sunscreen cream for the prevention of polymorphous light eruption: A double-blind, randomized, controlled study in maximized outdoor conditions. Cutis 2009, 83, 95–103. [Google Scholar]
  77. Fourtanier, A.; Moyal, D.; Seité, S. Sunscreens containing the broad-spectrum UVA absorber, Mexoryl® SX, the cutaneous detrimental effects of UV exposure: A review of clinical study results. Photodermatol. Photoimmunol. Photomed. 2008, 24, 164–174. [Google Scholar] [CrossRef]
  78. Mexoryl SW. Available online: https://cosmeticobs.com/en/ingredients/polyacrylamidomethyl-benzylidene-camphor-4382 (accessed on 3 June 2023).
  79. Spielmann, H.; Balls, M.; Dupuis, J.; Pape, W.J.W.; De Silva, O.; Holzhütter, H.G.; Gerberick, F.; Liebsch, M.; Lovell, W.W.; Pfannenbecker, U. A Study on UV Filter Chemicals from Annex VII of European Union Directive 76/768/EEC, in the in Vitro 3T3 NRU Phototoxicity Test. ATLA Altern. Lab. Anim. 1998, 26, 679–708. [Google Scholar] [CrossRef]
  80. Bernauer, U.; Bodin, L.; Chaudhry, Q.; Coenraads, P.J.; Dusinska, M.; Ezendam, J.; Gaffet, E.; Galli, C.L.; Granum, B.B.; Panteri, E. SCCS OPINION on Benzophenone-3 (CAS No 131-57-7, EC No 205-031-5)-SCCS/1625/20-Final Opinion; European Union: Luxembourg, 2021. [Google Scholar]
  81. Wnuk, W.; Michalska, K.; Krupa, A.; Pawlak, K. Benzophenone-3, a chemical UV-filter in cosmetics: Is it really safe for children and pregnant women? Postep. Dermatol. Alergol. 2022, 39, 26–33. [Google Scholar] [CrossRef]
  82. Mao, J.F.; Li, W.; Ong, C.N.; He, Y.; Jong, M.-C.; Gin, K.Y.-H. Assessment of human exposure to benzophenone-type UV filters: A review. Environ. Int. 2022, 167, 107405. [Google Scholar] [CrossRef] [PubMed]
  83. Imamović, B.; Trebše, P.; Omeragić, E.; Bečić, E.; Pečet, A.; Dedić, M. Stability and Removal of Benzophenone-Type UV Filters from Water Matrices by Advanced Oxidation Processes. Molecules 2022, 27, 1874. [Google Scholar] [CrossRef] [PubMed]
  84. Santos, A.J.M.; da Silva, J.C.G.E. Degradation studies of UV filter hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]-benzoate (DHHB) in aqueous solution. J. Contam. Hydrol. 2021, 236, 103740. [Google Scholar] [CrossRef]
  85. SCCS (Scientific Committee on Consumer Safety). Opinion on HAA299 (Nano), Preliminary Opinion 22 July 2021, Final Opinion 26-27 October 2021, SCCS/1634/2021; European Union: Luxembourg, 2021. [Google Scholar]
  86. Lawrence, K.P.; Sarkany, R.P.E.; Acker, S.; Herzog, B.; Young, A.R. A new visible light absorbing organic filter offers superior protection against pigmentation by wavelengths at the UVR-visible boundary region. J. Photochem. Photobiol. B Biol. 2022, 227, 112372. [Google Scholar] [CrossRef]
  87. Primary Sunscreen Monograph. Available online: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=sunscreen-ecransolaire (accessed on 2 June 2023).
  88. CFR—Code of Federal Regulations Title 21, Chapter I Subchapter D Part 352 Subpart B §352.10. Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=352.50 (accessed on 3 June 2023).
  89. Matta, M.K.; Zusterzeel, R.; Pilli, N.R.; Patel, V.; Volpe, D.A.; Florian, J.; Oh, L.; Bashaw, E.; Zineh, I.; Sanabria, C.; et al. Effect of Sunscreen Application under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. JAMA 2019, 321, 2082–2091. [Google Scholar] [CrossRef] [Green Version]
  90. Shedding More Light on Sunscreen Absorption|FDA. Available online: https://www.fda.gov/news-events/fda-voices/shedding-more-light-sunscreen-absorption (accessed on 10 June 2023).
  91. Wang, S.Q.; Lim, W. Sunscreen Photostability. In Principles and Practice of Photoprotection; Springer International Publishing: Cham, Switzerland, 2016; pp. 247–273. [Google Scholar]
  92. Lionetti, N.; Rigano, L. The new sunscreens among formulation strategy, stability issues, changing norms, safety and efficacy evaluations. Cosmetics 2017, 4, 15. [Google Scholar] [CrossRef] [Green Version]
  93. Dondi, D.; Albini, A.; Serpone, N. Interactions between different solar UVB/UVA filters contained in commercial suncreams and consequent loss of UV protection. Photochem. Photobiol. Sci. 2006, 5, 835–843. [Google Scholar] [CrossRef] [PubMed]
  94. Ceresole, R.; Han, Y.K.; Rosasco, M.A.; Orelli, L.R.; Segall, A. Drug-excipient compatibility studies in binary mixtures of avobenzone. J. Cosmet. Sci. 2013, 64, 317–328. [Google Scholar]
  95. Phenylbenzimidazole Sulfonic Acid—Sun Care—AAKO. Available online: https://www.aako.nl/products/sun-care/phenylbenzimidazole-sulfonic-acid/ (accessed on 2 June 2023).
  96. Annex VI Cosmetic Products Regulation—List of UV Filters Allowed in Cosmetic Products. Available online: https://lexparency.org/eu/32009R1223/ANX_VI/ (accessed on 2 June 2023).
  97. Bastien, N.; Millau, J.F.; Rouabhia, M.; Davies, R.J.H.; Drouin, R. The sunscreen agent 2-phenylbenzimidazole-5-sulfonic acid photosensitizes the formation of oxidized guanines in cellulo after UV-A or UV-B exposure. J. Investig. Dermatol. 2010, 130, 2463–2471. [Google Scholar] [CrossRef] [Green Version]
  98. Ji, Y.; Zhou, L.; Zhang, Y.; Ferronato, C.; Brigante, M.; Mailhot, G.; Yang, X.; Chovelon, J.M. Photochemical degradation of sunscreen agent 2-phenylbenzimidazole-5-sulfonic acid in different water matrices. Water Res. 2013, 47, 5865–5875. [Google Scholar] [CrossRef]
  99. Scalia, S.; Molinari, A.; Casolari, A.; Maldotti, A. Complexation of the sunscreen agent, phenylbenzimidazole sulphonic acid with cyclodextrins: Effect on stability and photo-induced free radical formation. Eur. J. Pharm. Sci. 2004, 22, 241–249. [Google Scholar] [CrossRef]
  100. Gomaa, Y.A.; El-Khordagui, L.K.; Boraei, N.A.; Darwish, I.A. Chitosan microparticles incorporating a hydrophilic sunscreen agent. Carbohydr. Polym. 2010, 81, 234–242. [Google Scholar] [CrossRef]
  101. Wongkom, L.; Jimtaisong, A. Novel biocomposite of carboxymethyl chitosan and pineapple peel carboxymethylcellulose as sunscreen carrier. Int. J. Biol. Macromol. 2017, 95, 873–880. [Google Scholar] [CrossRef] [PubMed]
  102. SymSelect: Sun Protection—A Deeper Knowledge. Available online: https://www.symselect.com/sun-protection (accessed on 2 June 2023).
  103. Sunscreen: How to Help Protect Your Skin from the Sun|FDA. Available online: https://www.fda.gov/drugs/understanding-over-counter-medicines/sunscreen-how-help-protect-your-skin-sun#ingredients (accessed on 2 June 2023).
  104. Balaguer, A.; Salvador, A.; Chisvert, A.; Meliá, M.; Herráez, M.; Díez, O. A liquid chromatography-fluorimetric method for the in vitro estimation of the skin penetration of disodium phenyldibenzimidazole tetrasulfonate from sunscreen formulations through human skin. Anal. Bioanal. Chem. 2006, 385, 1225–1232. [Google Scholar] [CrossRef] [PubMed]
  105. Farkas, R.; Lhiaubet-Vallet, V.; Corbera, J.; Törincsi, M.; Gorchs, O.; Trullas, C.; Jiménez, O.; Miranda, M.A.; Novak, L. Synthesis of new 2-(2′-hydroxyaryl)benzotriazoles and evaluation of their photochemical behavior as potential UV-filters. Molecules 2010, 15, 6205–6216. [Google Scholar] [CrossRef] [Green Version]
  106. Zhang, Y.; Shang, C.; Cao, Y.; Ma, M.; Sun, C. Insights into the photophysical properties of 2-(2′-hydroxyphenyl) benzazoles derivatives: Application of ESIPT mechanism on UV absorbers. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2022, 280, 121559. [Google Scholar] [CrossRef] [PubMed]
  107. Oguchi-Fujiwara, N.; Hatao, M.; Sakamoto, K. Chapter 35—Ultraviolet Care Cosmetics. In Cosmetic Science and Technology: Theoretical Principles and Applications; Sakamoto, K., Lochhead, R.Y., Maibach, H.I., Yamashita, Y., Eds.; Elsevier: Amsterdam, The Netherlands, 2017; pp. 587–599. [Google Scholar]
  108. Drometrizole Trisiloxane|C24H39N3O3Si3|CID 9848888—PubChem. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Drometrizole-trisiloxane (accessed on 3 June 2023).
  109. U.S. Department of Health and Human Services, Food and Drug Administration. Report in Response to the Sunscreen Innovation Act (P.L 113-195) Section 586G. Available online: https://www.fda.gov/media/113316/download (accessed on 3 June 2023).
  110. Ajay Babu, M.; Krishna Mohan, G.V.; Satish, J.; Kalariya, P.D.; Krishnam Raju, C.; Mankumare, S.D. A Sensitive, Stability indicating UPLC method for the identification and characterization of forced degradation products for Drometrizole Trisiloxane through MS n studies. J. Appl. Pharm. Sci. 2018, 8, 65–074. [Google Scholar]
  111. Pigatto, P.D.; Guzzi, G.; Schena, D.; Guarrera, M.; Foti, C.; Francalanci, S.; Cristaudo, A.; Ayala, F.; Vincenzi, C. Photopatch tests: An Italian multicentre study from 2004 to 2006. Contact Dermat. 2008, 59, 103–108. [Google Scholar] [CrossRef]
  112. Scientific Committee on Consumer Safety SCCS. Opinion on 2,2′-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (Nano Form) Submission III COLIPA n° S79; European Union: Luxembourg, 2015. [Google Scholar]
  113. TINOSORB® M. Available online: https://www.personal-care.basf.com/products-formulation/products/products-detail/TINOSORBM/30482916 (accessed on 3 June 2023).
  114. O’connell, M.; Kirk, S.; Wilkinson, M.S. Allergic contact dermatitis caused by Tinosorb M. Contact Dermat. 2011, 65, 48. [Google Scholar] [CrossRef]
  115. Monteiro, A.F.; Paulino, M.; Máquina, A.; Amaro, C.; Viana, I. Allergic contact dermatitis to decyl glucoside: Still an important allergen in Tinosorb M. Contact Dermat. 2020, 82, 126–128. [Google Scholar] [CrossRef]
  116. Pereira, N.; Coutinho, I.; Andrade, P.; Gonçalo, M. The UV Filter Tinosorb M, Containing Decyl Glucoside, Is a Frequent Cause of Allergic Contact Dermatitis. Dermatitis 2013, 24, 41–43. [Google Scholar] [CrossRef] [PubMed]
  117. Ashby, J.; Tinwell, H.; Plautz, J.; Twomey, K.; Lefevre, P.A. Lack of binding to isolated estrogen or androgen receptors, and inactivity in the immature rat uterotrophic assay, of the ultraviolet sunscreen filters Tinosorb M-active and Tinosorb S. Regul. Toxicol. Pharmacol. 2001, 34, 287–291. [Google Scholar] [CrossRef] [PubMed]
  118. Bos, J.D.; Meinardi, M.M.H.M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 2000, 9, 165–169. [Google Scholar] [CrossRef]
  119. Souza, C.; Maia Campos, P.M.B.G. Development of a HPLC method for determination of four UV filters in sunscreen and its application to skin penetration studies. Biomed. Chromatogr. 2017, 31, e4029. [Google Scholar] [CrossRef] [PubMed]
  120. Tampucci, S.; Tofani, G.; Chetoni, P.; Di Gangi, M.; Mezzetta, A.; Paganini, V.; Burgalassi, S.; Pomelli, C.S.; Monti, D. Sporopollenin Microcapsule: Sunscreen Delivery System with Photoprotective Properties. Pharmaceutics 2022, 14, 2041. [Google Scholar] [CrossRef]
  121. Chu, C.C.; Tan, C.P.; Hasan, Z.A.A.; Nyam, K.L. Preparation and evaluation of photoprotective kenaf seed oil nanocarriers-based cream of tocotrienol-rich fraction. Ind. Crops Prod. 2022, 185, 115164. [Google Scholar] [CrossRef]
  122. Chu, C.C.; Hasan, Z.A.A.; Tan, C.P.; Nyam, K.L. In vitro safety evaluation of sunscreen formulation from nanostructured lipid carriers using human cells and skin model. Toxicol. Vitr. 2022, 84, 105431. [Google Scholar] [CrossRef]
  123. Anna Wypych, G.W. Databook of UV Stabilizers; ChemTec Publishing: Toronto, ON, Canada, 2020. [Google Scholar]
  124. Uvasorb® HEB by 3V Sigma USA Inc.—Personal Care & Cosmetics. Available online: https://www.ulprospector.com/en/na/PersonalCare/Detail/1584/128630/Uvasorb-HEB (accessed on 4 June 2023).
  125. Couteau, C.; Chauvet, C.; Paparis, E.; Coiffard, L. UV Filters, Ingredients with a Recognized Anti-Inflammatory Effect. PLoS ONE 2012, 7, e46187. [Google Scholar] [CrossRef]
  126. Opinion on Benzoic Acid, 4,4-{[6-[[[(1,1-Dimethyl)amino]carbonyl]phenyl] amino]-1,3,5-triazine-2,4-diyl)diimino}bis-, bis(2-ethylhexyl)ester Scientific Committees. Available online: https://ec.europa.eu/health/scientific_committees/consumer_safety/opinions/sccnfp_opinions_97_04/sccp_out29_en.htm (accessed on 4 June 2023).
  127. Kima, S.H.; Debnatha, D.; Geckeler, K.E. Nanopumpkins and a sunscreen agent: The inclusion complex of cucurbituril and Tinosorb S. Supramol. Chem. 2011, 23, 337–341. [Google Scholar] [CrossRef]
  128. Puglia, C.; Damiani, E.; Offerta, A.; Rizza, L.; Tirendi, G.G.; Tarico, M.S.; Curreri, S.; Bonina, F.; Perrotta, R.E. Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-filters: Characterization, in vitro penetration and photostability studies. Eur. J. Pharm. Sci. 2014, 51, 211–217. [Google Scholar] [CrossRef]
  129. Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers Concerning 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-(1,3,5)-triazine. Available online: https://ec.europa.eu/health/archive/ph_risk/committees/sccp/documents/out52_en.pdf (accessed on 5 June 2023).
  130. Couteau, C.; Paparis, E.; Chauvet, C.; Coiffard, L. Tris-biphenyl triazine, a new ultraviolet filter studied in terms of photoprotective efficacy. Int. J. Pharm. 2015, 487, 120–123. [Google Scholar] [CrossRef] [PubMed]
  131. Scarpin, M.S.; Kawakami, C.M.; Rangel, K.C.; Pereira, K.d.C.; Benevenuto, C.G.; Gaspar, L.R. Effects of UV-filter Photostabilizers in the Photostability and Phototoxicity of Vitamin A Palmitate Combined with Avobenzone and Octyl Methoxycinnamate. Photochem. Photobiol. 2021, 97, 700–709. [Google Scholar] [CrossRef] [PubMed]
  132. Surber, C.; Plautz, J.; Dähnhardt-Pfeiffer, S.; Osterwalder, U. Nano is Bigger! Issues and challenges with nanoparticulate UV-filters (NP-UVF). J. Eur. Acad. Dermatol. Venereol. 2021, 35, e406–e408. [Google Scholar] [CrossRef]
  133. Scientific Committee on Consumer Safety (SCCS). Opinion on the Safety of Cosmetic Ingredients Phenylene Bis-Diphenyltriazine (CAS No 55514-22-2)—S86—Submission II SCCS/1594/18 Final Opinion. 2018. Available online: https://health.ec.europa.eu/system/files/2021-08/sccs_o_215_0.pdf (accessed on 4 June 2023).
  134. Bacqueville, D.; Jacques-Jamin, C.; Dromigny, H.; Boyer, F.; Brunel, Y.; Ferret, P.J.; Redoulès, D.; Douki, T.; Bessou-Touya, S.; Duplan, H. Phenylene Bis-Diphenyltriazine (TriAsorB), a new sunfilter protecting the skin against both UVB + UVA and blue light radiations. Photochem. Photobiol. Sci. 2021, 20, 1475–1486. [Google Scholar] [CrossRef]
  135. Bacqueville, D.; Jacques-Jamin, C.; Lapalud, P.; Douki, T.; Roullet, N.; Sereno, J.; Redoulès, D.; Bessou-Touya, S.; Duplan, H. Formulation of a new broad-spectrum UVB + UVA and blue light SPF50+ sunscreen containing Phenylene Bis-Diphenyltriazine (TriAsorB), an innovative sun filter with unique optical properties. J. Eur. Acad. Dermatol. Venereol. 2022, 36, 29–37. [Google Scholar] [CrossRef]
  136. Shirinian, V.Z.; Shimkin, A.A. Merocyanines: Synthesis and Application. In Heterocyclic Polymethine Dyes; Springer: Berlin/Heidelberg, Germany, 2008. [Google Scholar]
  137. Marionnet, C.; de Dormael, R.; Marat, X.; Roudot, A.; Gizard, J.; Planel, E.; Tornier, C.; Golebiewski, C.; Bastien, P.; Candau, D.; et al. Sunscreens with the New MCE Filter Cover the Whole UV Spectrum: Improved UVA1 Photoprotection In Vitro and in a Randomized Controlled Trial. JID Innov. 2022, 2, 100070. [Google Scholar] [CrossRef] [PubMed]
  138. de Dormael, R.; Bernerd, F.; Bastien, P.; Candau, D.; Roudot, A.; Tricaud, C. Improvement of photoprotection with sunscreen formulas containing the cyclic merocyanine UVA1 absorber MCE: In vivo demonstration under simulated and real sun exposure conditions in three randomised controlled trials. JEADV Clin. Pract. 2022, 1, 229–239. [Google Scholar] [CrossRef]
  139. de Dormael, R.; Tricaud, C.; Bastien, P.; Candau, D.; Roudot, A.; Bernerd, F. Gain of photoprotection afforded by the cyclic merocyanine UVA1 absorber MCE® in sunscreen formulae: A dose effect in vivo clinical trial. J. Cosmet. Dermatol. 2023, 22, 1929–1931. [Google Scholar] [CrossRef]
  140. Couteau, C.; Pommier, M.; Paparis, E.; Coiffard, L.J.M. Study of the efficacy of 18 sun filters authorized in European Union tested in vitro. Pharmazie 2007, 62, 449–452. [Google Scholar]
  141. Jansen, R.; Osterwalder, U.; Wang, S.Q.; Burnett, M.; Lim, H.W. Photoprotection: Part II. Sunscreen: Development, efficacy, and controversies. J. Am. Acad. Dermatol. 2013, 69, e1–e867. [Google Scholar] [CrossRef]
  142. Kullavanijaya, P.; Lim, H.W. Photoprotection. J. Am. Acad. Dermatol. 2005, 52, 937–962. [Google Scholar] [CrossRef]
  143. Gackowski, M.; Osmałek, T.; Froelich, A.; Otto, F.; Schneider, R.; Lulek, J. Phototoxic or Photoprotective?—Advances and Limitations of Titanium (IV) Oxide in Dermal Formulations—A Review. Int. J. Mol. Sci. 2023, 24, 8159. [Google Scholar] [CrossRef] [PubMed]
  144. Bartoszewska, M.; Adamska, E.; Kowalska, A.; Grobelna, B. Novelty Cosmetic Filters Based on Nanomaterials Composed of Titanium Dioxide Nanoparticles. Molecules 2023, 28, 645. [Google Scholar] [CrossRef] [PubMed]
  145. Karamanidou, T.; Bourganis, V.; Gatzogianni, G.; Tsouknidas, A. A Review of the EU’s Regulatory Framework for the Production of Nano-Enhanced Cosmetics. Metals 2021, 11, 455. [Google Scholar] [CrossRef]
  146. Schneider, S.L.; Lim, H.W. A review of inorganic UV filters zinc oxide and titanium dioxide. Photodermatol. Photoimmunol. Photomed. 2019, 35, 442–446. [Google Scholar] [CrossRef] [Green Version]
Figure 1. The structures of ethylhexyl dimethyl PABA (padimate O) and ethoxylated ethyl-4-aminobenzoate (PEG-25 PABA).
Figure 1. The structures of ethylhexyl dimethyl PABA (padimate O) and ethoxylated ethyl-4-aminobenzoate (PEG-25 PABA).
Cosmetics 10 00101 g001
Figure 2. The structures of 2-ethylhexyl salicylate (octisalate) and homosalate (homomenthyl salicylate).
Figure 2. The structures of 2-ethylhexyl salicylate (octisalate) and homosalate (homomenthyl salicylate).
Cosmetics 10 00101 g002
Figure 3. The structures of isopentyl 4-methoxycinnamate (amiloxate), 2-ethylhexyl 4-methoxycinnamate (octinoxate), 2-ethoxyethyl 4-methoxycinnamate (cinoxate), and octocrylene.
Figure 3. The structures of isopentyl 4-methoxycinnamate (amiloxate), 2-ethylhexyl 4-methoxycinnamate (octinoxate), 2-ethoxyethyl 4-methoxycinnamate (cinoxate), and octocrylene.
Cosmetics 10 00101 g003
Figure 4. The structures of 4-methylbenzylidene camphor (enzacamene), benzylidene camphor sulfonic acid, camphor benzalkonium methosulfate, and terephthalylidene dicamphor sulfonic acid.
Figure 4. The structures of 4-methylbenzylidene camphor (enzacamene), benzylidene camphor sulfonic acid, camphor benzalkonium methosulfate, and terephthalylidene dicamphor sulfonic acid.
Cosmetics 10 00101 g004
Figure 5. The structures of oxybenzone (benzophenone-3, BP-3), sulisobenzone (benzophenone-4, BP-4), dioxybenzone (benzophenone-8, BP-8), hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, and bis-(diethylaminohydroxybenzoyl benzoyl) piperazine.
Figure 5. The structures of oxybenzone (benzophenone-3, BP-3), sulisobenzone (benzophenone-4, BP-4), dioxybenzone (benzophenone-8, BP-8), hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, and bis-(diethylaminohydroxybenzoyl benzoyl) piperazine.
Cosmetics 10 00101 g005
Figure 6. The structure of avobenzone.
Figure 6. The structure of avobenzone.
Cosmetics 10 00101 g006
Figure 7. The structures of phenylbenzimidazole sulfonic acid (ensulizole), disodium phenyl dibenzimidazole tetrasulfonate (bisdisulizole disodium), drometrizole trisiloxane, and methylene bis-benzotriazolyl tetramethylbutylphenol (bisoctrizole).
Figure 7. The structures of phenylbenzimidazole sulfonic acid (ensulizole), disodium phenyl dibenzimidazole tetrasulfonate (bisdisulizole disodium), drometrizole trisiloxane, and methylene bis-benzotriazolyl tetramethylbutylphenol (bisoctrizole).
Cosmetics 10 00101 g007
Figure 8. The structures of triazine derivatives: ethylhexyl triazone, diethylhexyl butamido triazone (iscotrizinol), bis-ethylhexyloxyphenol methoxyphenyl triazine (bemotrizinol), tris-biphenyl triazine, and phenylene bis-diphenyltriazine.
Figure 8. The structures of triazine derivatives: ethylhexyl triazone, diethylhexyl butamido triazone (iscotrizinol), bis-ethylhexyloxyphenol methoxyphenyl triazine (bemotrizinol), tris-biphenyl triazine, and phenylene bis-diphenyltriazine.
Cosmetics 10 00101 g008
Figure 9. The structures of methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate, meradimate, and polysilicone-15.
Figure 9. The structures of methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate, meradimate, and polysilicone-15.
Cosmetics 10 00101 g009
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nitulescu, G.; Lupuliasa, D.; Adam-Dima, I.; Nitulescu, G.M. Ultraviolet Filters for Cosmetic Applications. Cosmetics 2023, 10, 101. https://doi.org/10.3390/cosmetics10040101

AMA Style

Nitulescu G, Lupuliasa D, Adam-Dima I, Nitulescu GM. Ultraviolet Filters for Cosmetic Applications. Cosmetics. 2023; 10(4):101. https://doi.org/10.3390/cosmetics10040101

Chicago/Turabian Style

Nitulescu, Georgiana, Dumitru Lupuliasa, Ines Adam-Dima, and George Mihai Nitulescu. 2023. "Ultraviolet Filters for Cosmetic Applications" Cosmetics 10, no. 4: 101. https://doi.org/10.3390/cosmetics10040101

APA Style

Nitulescu, G., Lupuliasa, D., Adam-Dima, I., & Nitulescu, G. M. (2023). Ultraviolet Filters for Cosmetic Applications. Cosmetics, 10(4), 101. https://doi.org/10.3390/cosmetics10040101

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop